Open original FDA record ↗Recall record
- FDA identifier
- Z-0934-2021
- Company in FDA record
- Brainreader ApS
- FDA record creation date
- Jan 29, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Neuroreader has been distributed with a reference normative database that is different from the version reviewed and cleared by FDA.
Source facts
- Action
- A Recall notification letter titled, "URGENT MEDICAL DEVICE CORRECTION" was sent to consignees on 12/14/2020 via a email. The consignee is requested to complete the attached recall acknowledgement form. Since the software is cloud-based, Neuroreader will be upgraded to Version 2.5 effective immediately to reflect the version of the reference normative database cleared by FDA. This correction will be implemented at no cost to the consignee. If the consignee experiences any adverse events or quality problems with the use of this product, they are to report this to FDAs MedWatch Adverse Event Reporting Program and to Brainreader as soon as possible. Distributors who further distributed products subject to this recall are asked to please identify customers immediately and notify them of the product recall using the Recall Notification Letter. The firm requests that the distributor direct their customers to contact the firm directly so that they could implement the correction. Brainreader will correct affected product at no cost. The distributor is also ask to please stop any sales of Neuroreader version 2.4. When version 2.5 is released sales can continue.
- Initiated
- 2020-12-14
- Root cause
- Under Investigation by firm
- Terminated
- 2021-08-12
- Distribution
- US Nationwide distribution including in the states of UT, PA, FL, AL, CA, MN, MD, MO, VA, DC, IL, TX, TN, MI, NY, IN, WA, WI, GA, MA.
- Recall number
- Z-0934-2021
- Recall status
- Terminated
- CDRH record ID
- 185013
- FDA record created
- 2021-01-29
- Recall event number
- 86995